THE EFFICACY OF SWITCHING FROM OTHER BASAL INSULIN TO INSULIN DEGLUDEC AMONG PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES ON INTENSIVE INSULIN THERAPY

被引：0
|
作者：
Kakizaki, Y. [1 ]
Sasaki, J. [1 ]
Sakakura, K. [2 ]
Tamaru, S. [1 ]
Shikuma, J. [1 ]
Ito, R. [1 ]
Miwa, T. [1 ]
Odawara, M. [1 ]
机构：
[1] Tokyo Med Univ, Dept Diabet Endcrinol & Metab, Tokyo 1608402, Japan
[2] Tokyo Med Univ, Dept Pharm, Tokyo 1608402, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70552-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO258
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [1] Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec
    Blanquez Martinez, David
    Hayon Ponce, Maria
    Caballero Romero, Alvaro
    Diaz Villamarin, Xando
    Nieto Gomez, Pelayo
    Moron Romero, Rocio
    Davila Fajardo, Cristina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 301 - 302
  • [2] Clinical Utility of Switching to Insulin Degludec from Other Basal Insulins in Patients with Type 1 or 2 Diabetes
    Baran, O.
    Dersch-Mills, D.
    Bakal, J.
    Arbo, T.
    Hnatiuk, M.
    Roedler, R.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2021, 74 (02): : 185 - 185
  • [3] Clinical Utility of Switching to Insulin Degludec From Other Basal Insulins in Adult Patients With Type 1 or Type 2 Diabetes
    Baran, Oleksandr
    Dersch-Mills, Deonne
    Bakal, Jeffrey A.
    Huyghebaert, Trudy
    Hnatiuk, Melanie
    Roedler, Rhonda L.
    CANADIAN JOURNAL OF DIABETES, 2022, 46 (04) : 381 - +
  • [4] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
    Urakami, Tatsuhiko
    Habu, Masako
    Okuno, Misako
    Suzuki, Junichi
    Takahashi, Shori
    DIABETES, 2014, 63 : A323 - A323
  • [5] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes
    Yamada K.
    Nakayama H.
    Sato S.
    Tajiri Y.
    Kaku H.
    Tokubuchi I.
    Kato T.
    Soejima E.
    Ohki T.
    Diabetology International, 2014, 5 (1) : 74 - 77
  • [6] EFFICACY OF INSULIN DEGLUDEC AFTER SWITCHING FROM INSULIN GLARGINE OR INSULIN DETEMIR IN YOUNG PERSONS WITH TYPE 1 DIABETES
    Urakami, T.
    Kuwabara, R.
    Habu, M.
    Okuno, M.
    Suzuki, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S235 - S236
  • [7] Efficacy and safety of switching from insulin glargine to insulin degludec in young people with type 1 diabetes
    Urakami, Tatsuhiko
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2016, 63 (02) : 159 - 167
  • [8] Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study
    Yoshiyuki Hamamoto
    Sachiko Honjo
    Kanta Fujimoto
    Shinsuke Tokumoto
    Hiroki Ikeda
    Yoshiharu Wada
    Hiroyuki Koshiyama
    Clinical Drug Investigation, 2017, 37 : 845 - 852
  • [9] Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study
    Hamamoto, Yoshiyuki
    Honjo, Sachiko
    Fujimoto, Kanta
    Tokumoto, Shinsuke
    Ikeda, Hiroki
    Wada, Yoshiharu
    Koshiyama, Hiroyuki
    CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 845 - 852
  • [10] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
12345